Technical Analysis for ALVR - AlloVir, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| 20 DMA Resistance | Bearish | 1.41% | |
| Fell Below 50 DMA | Bearish | 1.41% | |
| MACD Bearish Centerline Cross | Bearish | 1.41% | |
| Stochastic Sell Signal | Bearish | 1.41% | |
| Weak + Overbought | Other | 1.41% | |
| Overbought Stochastic | Strength | 1.41% | |
| Gapped Down | Weakness | 1.41% |
| Alert | Time |
|---|---|
| Gap Up Partially Closed | 3 days ago |
| Gapped Up (Partial) | 4 days ago |
| 10 DMA Support | 4 days ago |
| 50 DMA Support | 4 days ago |
| Rose Above 50 DMA | 4 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/06/2024
AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir’s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Stem Cell Cell Therapy Cell Biology Gene Therapy Manufacturing Process Viruses Virus Viral Disease Immunity Covid 19 Zoonoses
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Immune System Stem Cell Cell Therapy Cell Biology Gene Therapy Manufacturing Process Viruses Virus Viral Disease Immunity Covid 19 Zoonoses
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.1 |
| 52 Week Low | 0.58 |
| Average Volume | 458,166 |
| 200-Day Moving Average | 1.41 |
| 50-Day Moving Average | 0.77 |
| 20-Day Moving Average | 0.78 |
| 10-Day Moving Average | 0.76 |
| Average True Range | 0.05 |
| RSI (14) | 46.24 |
| ADX | 38.86 |
| +DI | 6.85 |
| -DI | 26.23 |
| Chandelier Exit (Long, 3 ATRs) | 0.68 |
| Chandelier Exit (Short, 3 ATRs) | 0.72 |
| Upper Bollinger Bands | 0.83 |
| Lower Bollinger Band | 0.74 |
| Percent B (%b) | 0.21 |
| BandWidth | 11.55 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | -0.0037 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.80 | ||||
| Resistance 3 (R3) | 0.81 | 0.79 | 0.80 | ||
| Resistance 2 (R2) | 0.79 | 0.78 | 0.79 | 0.79 | |
| Resistance 1 (R1) | 0.78 | 0.77 | 0.77 | 0.77 | 0.79 |
| Pivot Point | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 |
| Support 1 (S1) | 0.74 | 0.75 | 0.74 | 0.74 | 0.72 |
| Support 2 (S2) | 0.73 | 0.74 | 0.73 | 0.72 | |
| Support 3 (S3) | 0.71 | 0.73 | 0.72 | ||
| Support 4 (S4) | 0.71 |
